Navigation Links
BioMarin Announces Third Quarter 2011 Financial Results
Date:10/27/2011

: Initiation of Phase II trial for BMN-111 for Achondroplasia
4Q 2013: Anticipated regulatory approval of GALNS for MPS IVA

Research and Development ProgramsBioMarin continues to make significant investments in research and development to ensure persistent growth for the company.  The current pipeline includes programs in various stages of development that are focused on treating a range of serious unmet medical needs.  BioMarin will host an R&D Day on Thursday, December 8th in New York to discuss its clinical and preclinical pipeline in detail.Advanced Clinical Programs

  • GALNS for MPS IVA: BioMarin is enrolling patients in a randomized, double-blind, placebo-controlled Phase III study with primary endpoint of six-minute walk distance.  The study will be 24 weeks in treatment duration with treatment doses of two mg/kg/week and two mg/kg/every other week.  The company expects to enroll approximately 160 patients across 40 centers worldwide and is on track to report top-line results in the second half of 2012.  
  • Kuvan Outcomes Study: PKU-016, a randomized, placebo-controlled, 13-week Kuvan outcomes study is ongoing.  Endpoints include clinically validated measures of neuropsychiatric symptoms and, if successful, may enable a label amendment.  The company expects to report top-line results in the second half of 2012.
  • Firdapse: The Phase III trial for LEMS for FDA approval in the U.S. is ongoing.

  • Mid-Stage Clinical Programs

  • PEG-PAL for PKU: The company will provide an update on the Phase II study at the R&D Day in December.  The company expects to initiate a Phase III trial in the second half of 2012.
  • Hand-Held Blood Phe Monitor: Regulatory clearance and commercial availability of the handheld blood Phe monitor are expected in the second half of 2013.

  • Early-Stage Clinical Programs

  • BMN
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. BioMarin to Present at the UBS Global Life Sciences Conference
    2. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
    3. BioMarin to Present at the Baird Health Care Conference
    4. BioMarin to Present at the Wedbush Life Sciences Conference
    5. BioMarin Announces Second Quarter 2011 Financial Results
    6. BioMarin to Host Second Quarter 2011 Financial Results Conference Call and Webcast on Thursday, July 28 at 5:00 p.m. ET
    7. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
    8. BioMarin to Present at the William Blair Growth Stock Conference
    9. BioMarin to Present at the Jefferies Global Healthcare Conference
    10. BioMarin to Present at the Bank of America Merrill Lynch Healthcare Conference
    11. BioMarin Announces First Quarter 2011 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/30/2015)... , April 30, 2015  Accuray Incorporated ... has signed an agreement with MIM Software Inc. ... TomoTherapy ® and CyberKnife ® product portfolios. ... and MIM technology. This is Accuray,s second collaboration ... development of the first iPad-based treatment plan review ...
    (Date:4/30/2015)... DIEGO, April 30, 2015  Tandem Diabetes Care ® , ... manufacturer of the t:slim ® and t:flex™ Insulin Pumps, ... 31, 2015. In comparing the first quarter ... Sales grew 53 percent to $12.3 million from $8.1 million ... pumps from 1,723 pumps "Our investment in resources ...
    (Date:4/30/2015)...   Regulus Therapeutics Inc . (NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that it ... ended March 31, 2015 on Thursday, May 7, 2015, ... Regulus will host a conference call and webcast on ... Time to discuss its first quarter 2015 financial results ...
    Breaking Medicine Technology:Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 2Tandem Diabetes Care Reports First Quarter 2015 Financial Results 3Tandem Diabetes Care Reports First Quarter 2015 Financial Results 4Tandem Diabetes Care Reports First Quarter 2015 Financial Results 5Tandem Diabetes Care Reports First Quarter 2015 Financial Results 6Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
    ... 2011 /PRNewswire-Asia/ -- Pharmaceutical company Hatchtech Pty Ltd has ... study to confirm the efficacy of its novel head ... is evaluating the efficacy, safety and tolerability of two ... to vehicle. The trial consists of treating 132 healthy ...
    ... Aug. 31, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... appointed Helen Torley, M.B. Ch. B., M.R.C.P.,  as Executive ... Dr. Torley will report to N. Anthony Coles, M.D., ... for all commercial activities related to Nexavar and the ...
    Cached Medicine Technology:Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 2Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 3Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 2Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer 3
    (Date:5/3/2015)... Indiana Fiber Network, LLC (IFN), the leading ... Inc (BCS) has selected IFN as a fiber transport ... service, and working relationship with IFN has been great, ... you get with IFN. I like dealing with ... decisions and operates as a local community business partner.” ...
    (Date:5/3/2015)... (PRWEB) May 03, 2015 SpineFrontier, a ... from the FDA to produce and market their new ... can be used in outpatient settings and is compatible ... alternate posterior approach has been extensively researched and refined ... approval to use this approach in conjunction with a ...
    (Date:5/2/2015)... NV (PRWEB) May 02, 2015 Ticket Down ... tickets for the long awaited event today, Saturday, May ... Diehard boxing fans will be able to secure tickets ... , The fight that boxing fans have wanted for more ... months ago. Floyd “Money” Mayweather will step inside the ring ...
    (Date:5/2/2015)... May 02, 2015 It’s a pattern ... natural disaster strikes anywhere on this planet, cyber scammers ... sympathy and compassion for their own personal gain. ... Emergency Readiness Team) issued an alert titled “Nepal ... email scams citing the earthquake in Nepal. The scam ...
    (Date:5/2/2015)... Kare Visits LLC. launched in Chicago in ... Kare Visits offers relief for caregivers by visiting loved ... According to the Caregiver Action Network, eight in ten ... hours a week caring for an elderly or disabled loved ... a nurse, a caregiver is now empowered to schedule an ...
    Breaking Medicine News(10 mins):Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
    ... ... affordable drug and alcohol rehab programs. Mountainside in Connecticut cites a sharp increase in demand ... increase in alcoholic binge drinking, drug abuse and marital problems. , ... (PRWEB) December 3, 2009 -- Mountainside Affordable Addiction Treatment ...
    ... Dec. 3 The American Association for Cancer Research (AACR) ... date on passive smoking and breast cancer in women conducted ... , Study data revealed that women who never smoked ... a lifetime--especially during adulthood--had a significantly increased breast cancer risk ...
    ... , PASADENA, Calif., ... businesses, the risk of disability remains one of the most ... but also their business,s viability. , "As the recession ... businesses are recognizing the need to shore up their financial ...
    ... , WAYNE, Pa., Dec. ... InterComponentWare Inc. (ICW), a global leader in eHealth technology, to ... Exchange (HIE). ICW will implement its Enterprise Master Patient ... (IPF) across 6 counties, 470,000 residents, 8 hospitals, and over ...
    ... replicating in the livers of primates , , THURSDAY, Dec. ... C has shown promise in a primate study. , The ... hepatitis C virus from replicating. Unlike other antivirals that target ... RNA molecule in the liver that hepatitis C needs to ...
    ... The following is being released by Common Cause ... Patrick Leahy (D-Vt.) is offering an amendment to the ... insurance industry,s legal exemptions for violations such as price ... fiercely opposes the repeal, which would subject health insurance ...
    Cached Medicine News:Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Southern Tier HealthLink NY Selects InterComponentWare to Deliver Core Components of HIE 2Health News:New Hepatitis C Treatment Shows Promise 2Health News:New Hepatitis C Treatment Shows Promise 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: